FDA Drug Approval Guidance: What You Need to Know
Federal regulators may set clinical trial enrollment targets and impose other conditions on certain studies that pharmaceutical companies must carry out under an accelerated drug-approval program, according to new draft guidance...To view the full article, register now.
Already a subscriber? Click here to view full article